Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NCT04105374 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped NCI approval withdrawn

Conditions

Anaplastic Astrocytoma
Glioblastoma
Oligodendroglioma
Supratentorial Glioblastoma

Interventions

DRUG: Extended Release Flucytosine
DEVICE: NovoTTF-100A Device
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
DRUG: Temozolomide
PROCEDURE: Therapeutic Conventional Surgery
BIOLOGICAL: Vocimagene Amiretrorepvec

Sponsor

NRG Oncology

Collaborators

[object Object]